{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:48:36Z","timestamp":1789051716914,"version":"build-2803163510"},"reference-count":152,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T00:00:00Z","timestamp":1625616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>IgG4-related disease (IgG4-RD) is a rare systemic fibroinflammatory disease frequently associated with allergy. The pathogenesis of IgG4-RD is poorly understood, and effective therapies are limited. However, IgG4-RD appears to involve some of the same pathogenic mechanisms observed in allergic disease, such as T helper 2 (Th2) and regulatory T cell (Treg) activation, IgG4 and IgE hypersecretion, and blood\/tissue eosinophilia. In addition, IgG4-RD tissue fibrosis appears to involve activation of basophils and mast cells and their release of alarmins and cytokines. In this article, we review allergy-like features of IgG4-RD and highlight targeted therapies for allergy that have potential in treating patients with\u00a0IgG4-RD.<\/jats:p>","DOI":"10.3389\/fimmu.2021.693192","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T05:38:09Z","timestamp":1625636289000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":52,"title":["Allergic Aspects of IgG4-Related Disease: Implications for Pathogenesis and Therapy"],"prefix":"10.3389","volume":"12","author":[{"given":"Despina","family":"Michailidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella Muallem","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Mustelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant C.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related Disease","volume":"366","author":"Stone","year":"2012","journal-title":"New Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/BOR.0b013e3283418057","article-title":"A Clinical Overview of IgG-4 Related Systemic Disease","volume":"23","author":"Khosroshahi","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.06.003","article-title":"The Changing Faces of IgG4-Related Disease: Clinical Manifestations and Pathogenesis","volume":"14","author":"Islam","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/cei.12641","article-title":"Immunology of IgG4-Related Disease","volume":"181","author":"Della-Torre","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.cgh.2017.02.007","article-title":"Increases in IgE, Eosinophils, and Mast Cells, can be Used in Diagnosis and to Predict Relapse of IgG4-Related Disease","volume":"15","author":"Culver","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nature07204","article-title":"The Development of Allergic Inflammation","volume":"454","author":"Galli","year":"2008","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000315936","article-title":"T-Cell Response to Allergens","volume":"95","author":"Ozdemir","year":"2010","journal-title":"Chem Immunol Allergy"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00364","article-title":"Il-33: Roles in Allergic Inflammation and Therapeutic Perspectives","volume":"10","author":"Chan","year":"2019","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-020-0271-0","article-title":"Thymic Stromal Lymphopoietin Protects in a Model of Airway Damage and Inflammation Via Regulation of Caspase-1 Activity and Apoptosis Inhibition","volume":"13","author":"Shubin","year":"2020","journal-title":"Mucosal Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2017.08.001","article-title":"IL-1 Family Cytokines and Receptors in IgG4-Related Disease. IL-1 Family Cytokines and Receptors in IgG4-Related Disease","volume":"102","author":"Capecchi","year":"2018","journal-title":"Cytokine"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.01.044","article-title":"Thymic Stromal Lymphopoietin-Induced Human Asthmatic Airway Epithelial Cell Proliferation Through an IL-13-Dependent Pathway","volume":"125","author":"Semlali","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2015.318","article-title":"TSLP Directly Interacts With Skin-Homing Th2 Cells Highly Expressing Its Receptor to Enhance IL-4 Production in Atopic Dermatitis","volume":"135","author":"Tatsuno","year":"2015","journal-title":"J Invest Dermatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cyto.2015.05.008","article-title":"The Differential Expression of IL-4 and IL-13 and Its Impact on Type-2 Immunity","volume":"75","author":"Bao","year":"2015","journal-title":"Cytokine"},{"key":"B14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1146\/annurev-immunol-051116-052350","article-title":"Th2 Cells in Health and Disease","volume":"35","author":"Nakayama","year":"2017","journal-title":"Annu Rev Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nri.2017.90","article-title":"Type 2 Immunity in Tissue Repair and Fibrosis","volume":"18","author":"Gieseck","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/nm.2755","article-title":"Ige and Mast Cells in Allergic Disease","volume":"18","author":"Galli","year":"2012","journal-title":"Nat Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.603050","article-title":"Ige and IgG Antibodies as Regulators of Mast Cell and Basophil Functions in Food Allergy","volume":"11","author":"Kanagaratham","year":"2020","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21697","article-title":"Th2 and Regulatory Immune Reactions are Increased in Immunoglobulin G4-Related Sclerosing Pancreatitis and Cholangitis","volume":"45","author":"Zen","year":"2007","journal-title":"Hepatology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/art.33320","article-title":"Th2 and Regulatory Immune Reactions Contribute to IgG4 Production and the Initiation of Mikulicz Disease","volume":"64","author":"Tanaka","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/35095579","article-title":"The Germless Theory of Allergic Disease: Revisiting the Hygiene Hypothesis","volume":"1","author":"Wills-Karp","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"eaam9171","DOI":"10.1126\/scitranslmed.aam9171","article-title":"A Phenotypically and Functionally Distinct Human TH2 Cell Subpopulation is Associated With Allergic Disorders","volume":"9","author":"Wambre","year":"2017","journal-title":"Sci Transl Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21145082","article-title":"The Cellular and Molecular Bases of Allergy, Inflammation and Tissue Fibrosis in Patients With IgG-related Disease","volume":"21","author":"Hsieh","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex171","article-title":"Follicular Helper T Cells in the Pathogenesis of IgG4-Related Disease","volume":"57","author":"Akiyama","year":"2018","journal-title":"Rheumatol (Oxford)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60720-0","article-title":"IgG4-related Disease","volume":"385","author":"Kamisawa","year":"2015","journal-title":"Lancet"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/art.40469","article-title":"A CD8a-Subset of CD4+SLAMF7+ Cytotoxic T Cells is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucorticoid Treatement","volume":"70","author":"Della Torre","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.12.1330","article-title":"Clonal Expansion of CD4+ Cytotoxic T Lymphocytes in Patients With IgG4-Related Disease","volume":"138","author":"Mattoo","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209139","article-title":"Lesional CD4+ IFN-Gamma+ Cytotoxic T Lymphocytes in IgG4-Related Dacryoadenitis and Sialoadenitis","volume":"76","author":"Maehara","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.159.5.9805080","article-title":"Reduced Interferon-G Production in Infants With Bronchiolitis and Asthma","volume":"159","author":"Renzi","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/ACI.0000000000000480","article-title":"Role of Allergen-Specific T-follicular Helper Cells in Immunotherapy","volume":"18","author":"Yao","year":"2018","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601507","article-title":"Cutting Edge: A Critical Role of Lesional T Follicular Helper Cells in the Pathogenesis of IgG4-Related Disease","volume":"199","author":"Kamekura","year":"2017","journal-title":"J Immunol"},{"key":"B31","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.160.7.3555","article-title":"Ige Versus IgG4 Production can be Differentially Regulated by IL-10","volume":"160","author":"Jeannin","year":"1998","journal-title":"J Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2005.01.001","article-title":"Il-21 Effects on Human IgE Production in Response to IL-4 or IL-13","volume":"231","author":"Wood","year":"2004","journal-title":"Cell Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2018.05.009","article-title":"Interleukin-4 Contributes to the Shift of Balance of IgG Subclasses Toward IgG4 in IgG4-related Disease","volume":"110","author":"Akiyama","year":"2018","journal-title":"Cytokine"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00065","article-title":"Cytokine-Mediated Regulation of Plasma Cell Generation: IL-21 Takes Center Stage","volume":"5","author":"Moens","year":"2014","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxu074","article-title":"IgG4-related Disease and Its Pathogenesis-Cross-Talk Between Innate and Acquired Immunity","volume":"26","author":"Umehara","year":"2014","journal-title":"Int Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11882-016-0621-x","article-title":"The Developmental History of IgE and IgG4 Antibodies in Relation to Atopy, Eosinophilic Esophagitis, and the Modified TH2 Response","volume":"16","author":"Aalberse","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/nri3795","article-title":"The Generation of Antibody-Secreting Plasma Cells","volume":"15","author":"Nutt","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/08916934.2017.1280029","article-title":"Clonally Expanded Cytotoxic CD4+ T Cells and the Pathogenesis of IgG4-Related Disease","volume":"50","author":"Mattoo","year":"2017","journal-title":"Autoimmunity"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-016-0142-y","article-title":"Treatment of IgG4-related Disease: Current and Future Approaches","volume":"75","author":"Perugino","year":"2016","journal-title":"Z Rheumatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.03.034","article-title":"De Novo Oligoclonal Expansions of Circulating Plasmablasts in Active and Relapsing IgG4-related Disease","volume":"134","author":"Mattoo","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20140066","article-title":"Immunoglobulin E Plays an Immunoregulatory Role in Lupus","volume":"211","author":"Dema","year":"2014","journal-title":"J Exp Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/art.40828","article-title":"Safety and Tolerability of Omalizumab, A Randomized Clinical Trial of Humanized Anti-Ige Monoclonal Antibody in Systemic Lupus Erythematosus (Stop Lupus)","volume":"71","author":"Hasni","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3349\/ymj.2010.51.6.797","article-title":"Mast Cells in Allergic Asthma and Beyond","volume":"51","author":"Reuter","year":"2010","journal-title":"Yonsei Med J"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/jaci.2016.07.022","article-title":"Role of IgG4 in IgE-Mediated Allergic Responses","volume":"138","author":"van de Veen","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/all.13167","article-title":"Natural Tolerance Development in Cow\u2019s Milk Allergic Children: IgE and IgG4 Epitope Binding","volume":"72","author":"Caubet","year":"2017","journal-title":"Allergy"},{"key":"B46","article-title":"Allergic Diseases, Immunoglobulin E, and Autoimmune Pancreatitis: A Retrospective Study of 22 Patients","volume":"127","author":"Zhang","year":"2014","journal-title":"Chin Med J"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04168-4","article-title":"Sensitisation, Asthma, and a Modified Th2 Response in Children Exposed to Cat Allergen: A Population-Based Cross-Sectional Study","volume":"357","author":"Platts-Mills","year":"2001","journal-title":"Lancet"},{"key":"B48","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41467-017-00723-0","article-title":"IgG1 Memory B Cells Keep the Memory of IgE Responses","volume":"8","author":"He","year":"2017","journal-title":"Nat Commun"},{"key":"B49","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/ni.2256","article-title":"IgE+ Memory Plasma Cells Generated Through a Germinal-Center Pathway","volume":"13","author":"Talay","year":"2012","journal-title":"Nat Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.07.014","article-title":"Human B Cell Isotype Switching Origins of Ige","volume":"137","author":"Looney","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jaci.2013.07.044","article-title":"Phenotypic Differences Between IgG4+ and IgG1+B Cells Point to Distinct Regulation of the IgG4 Response","volume":"133","author":"Lighaam","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/nri2782","article-title":"Mast Cell-Orchestrated Immunity to Pathogens","volume":"10","author":"Abraham Soman","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.1038\/s41597-018-23043-9","article-title":"Mast Cells Exhibiting Strong Cytoplasmic Staining for IgE and High Affinity IgE Receptor are Increased in IgG4-Related Disease","volume":"8","author":"Nishida","year":"2018","journal-title":"Sci Rep"},{"key":"B54","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/cea.12675","article-title":"Mast Cells in Asthma\u2013State of the Art","volume":"46","author":"Bradding","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"B55","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/imr.12626","article-title":"The Controversial Role of Mast Cells in Fibrosis","volume":"282","author":"Bradding","year":"2018","journal-title":"Immunol Rev"},{"key":"B56","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cyto.2015.05.010","article-title":"T Helper 2 (Th2) Cell Differentiation, Type2 Innate Lymphoid Cell (ILC2) Development and Regulation of Interleukin-4 (IL-4) and IL-13","volume":"75","author":"Zhu","year":"2015","journal-title":"Cytokine"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.8.3730","article-title":"Interleukin 13 Induces Interleukin 4-Independent IgG4 and IgE Synthesis and CD23 Expression by Human B Cells","volume":"90","author":"Punnonen","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.12.936","article-title":"Key Advances in Mechanisms of Asthma, Allergy, and Immunology in 2009","volume":"125","author":"Finkelman","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00715","article-title":"Non-Classical B Cell Memory of Allergic Ige Responses","volume":"10","author":"Saunders","year":"2019","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2018.1526357","article-title":"Interleukin 5-Producing ST2+ Memory Th2 Cells in IgG4-Related Dacryoadenitis and Sialadenitis","volume":"29","author":"Yamamoto","year":"2019","journal-title":"Mod Rheumatol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.6.3498","article-title":"Primary T Cell Expansion and Differentiation In Vivo Requires Antigen Presentation by B Cells","volume":"176","author":"Crawford","year":"2006","journal-title":"J Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000445215","article-title":"A Player and Coordinator: The Versatile Roles of Eosinophils in the Immune System","volume":"43","author":"Long","year":"2016","journal-title":"Transfus Med Hemother"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2009.137","article-title":"Emerging Functions of Basophils in Protective and Allergic Immune Responses","volume":"3","author":"Sokol","year":"2010","journal-title":"Mucosal Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-012419-032756","article-title":"Contributions of Eosinophils to Human Health and Disease","volume":"15","author":"Klion","year":"2020","journal-title":"Annu Rev Pathol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"16483","DOI":"10.1038\/s41598-019-52847-6","article-title":"Different Clinical Patterns of IgG4-RD Patients With and Without Eosinophilia","volume":"9","author":"Zhang","year":"2019","journal-title":"Sci Rep"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.10.5470","article-title":"Eosinophils and T Lymphocytes Possess Distinct Roles in Bleomycin-Induced Lung Injury and Fibrosis","volume":"171","author":"Huaux","year":"2003","journal-title":"J Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-012-0626-8","article-title":"Toll-Like Receptor Activation in Basophils Contributes to the Development of IgG4-related Disease","volume":"48","author":"Watanabe","year":"2013","journal-title":"J Gastroenterol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2013.183","article-title":"Mechanisms and Assessment of IgG4-Related Disease: Lessons for the Rheumatologist","volume":"10","author":"Yamamoto","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2020.100047","article-title":"Immunological Mechanisms of IgG4-related Disease","volume":"3","author":"Liu","year":"2020","journal-title":"J Transl Autoimmun"},{"key":"B70","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/imr.12577","article-title":"Alarmins and Immunity","volume":"280","author":"Yang","year":"2017","journal-title":"Immunol Rev"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0524-9","article-title":"TSLP: From Allergy to Cancer","volume":"20","author":"Corren","year":"2019","journal-title":"Nat Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/s10735-018-9796-x","article-title":"Mechanism of Fibrogenesis in Submandibular Glands in Patients With Igg4-RD","volume":"49","author":"Yajima","year":"2018","journal-title":"J Mol Histol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/s0091-6749(99)70281-2","article-title":"Chemokines and Allergic Disease","volume":"104","author":"Nickel","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jaci.2008.09.049","article-title":"Contribution of CCR4 and CCR8 to Antigen-Specifc T(H)2 Cell Trafficking in Allergic Pulmonary Infammation","volume":"123","author":"Mikhak","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"6010","DOI":"10.1038\/s41598-020-62941-9","article-title":"Thymus and Activation-Regulated Chemokine as a Biomarker for IgG4-related Disease","volume":"10","author":"Umeda","year":"2020","journal-title":"Sci Rep"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/5931865","article-title":"Interleukin-35 in Asthma and its Potential as an Effective Therapeutic Agent","volume":"2017","author":"Gao","year":"2017","journal-title":"Mediators Inflamm"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-014-0038-4","article-title":"Aberrant Expression of Regulatory Cytokine IL-35 and Pattern Recognition Receptor NOD2 in Patients With Allergic Asthma","volume":"38","author":"Wong","year":"2015","journal-title":"Inflammation"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-020-01689-5","article-title":"Interleukin-35 Promotes the Differentiation of Regulatory T Cells and Suppresses Th2 Response in IgG4-Related Type 1 Autoimmune Pancreatitis","volume":"55","author":"Ito","year":"2020","journal-title":"J Gastroenterol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-020-08803-8","article-title":"Interleukin-35 Promotes Th9 Cell Differentiation in IgG4-Related Disorders: Experimental Data and Review of the Literature","volume":"60","author":"Zhang","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.114238","article-title":"Role of IL-9 in the Pathophysiology of Allergic Disease","volume":"107","author":"Soussi-Gounni","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(19)30006-2","article-title":"IgG4-related Disease in the Japanese Population: A Genome-Wide Association Study","volume":"1","author":"Terao","year":"2019","journal-title":"Lancet Rheumatol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.1998.00224.x","article-title":"HLA Class II Drb1, DQB1 and DPB1 Genotypic Associations With Peanut Allergy: Evidence From a Family-Based and Case-Control Study","volume":"28","author":"Howell","year":"1998","journal-title":"Clin Exp Allergy"},{"key":"B83","doi-asserted-by":"publisher","first-page":"e89196","DOI":"10.1371\/journal.pone.0089196","article-title":"Functional Fcgamma Receptor Polymorphisms Are Associated With Human Allergy","volume":"9","author":"Wu","year":"2014","journal-title":"PloS One"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181f7266b","article-title":"IgG4-related Disease: A Cross-Sectional Study of 114 Cases","volume":"34","author":"Zen","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.089169","article-title":"Proposal for a New Clinical Entity, IgG4-positive Multiorgan Lymphoproliferative Syndrome: Analysis of 64 Cases of IgG4-related Disorders","volume":"68","author":"Masaki","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2015.12.003","article-title":"Asthma and Orbital Immunoglobulin G4-related Disease","volume":"116","author":"Baqir","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3346\/jkms.2014.29.4.599","article-title":"A Case of IgG4-related Disease With Bronchial Asthma and Chronic Rhinosinusitis in Korea","volume":"29","author":"Lee","year":"2014","journal-title":"J Korean Med Sci"},{"key":"B88","doi-asserted-by":"publisher","first-page":"e1916","DOI":"10.1097\/MD.0000000000001916","article-title":"Adult Onset Athma and Periocular Xanthogranuloma (AAPOX), a Rare Entity With a Strong Link to IgG4-related Disease: An Observational Case Report Study","volume":"94","author":"London","year":"2015","journal-title":"Med (Baltimore)"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e11143","DOI":"10.1097\/MD.0000000000011143","article-title":"Sustained Clinical Response After Single Course of Rituximab as First-Line Monotherapy in Adult-Onset Asthma and Periocular Xanthogranulomas Syndrome Associated With IgG4-Related Disease: A Case Report","volume":"97","author":"Pomponio","year":"2018","journal-title":"Med (Baltimore)"},{"key":"B90","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.rmed.2016.01.014","article-title":"What are the Characteristics of Asthma Patients With Elevated Serum IgG4 Levels","volume":"112","author":"Flament","year":"2016","journal-title":"Respir Med"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2004.05.048","article-title":"Immunoglobulin Allotypes and IgG Subclass Antibody Response to Aspergillus Fumigatus in Cystic Fibrosis Patients","volume":"3","author":"Skov","year":"2004","journal-title":"J Cyst Firbros"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-018-5013-5","article-title":"IgG4-related Disease: Association Between Chronic Rhino-Sinusitis and Systemic Symptoms","volume":"275","author":"Gao","year":"2018","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.2500\/ar.2015.6.0136","article-title":"A Rare and Emerging Entity: Sinonasal IgG4-related Sclerosing Disease","volume":"6","author":"Song","year":"2015","journal-title":"Allergy Rhinol (Providence)"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2009.07.073","article-title":"A Rare Case of IgG4-related Sclerosing Disease of the Maxillary Sinus Associated With Bone Destruction","volume":"68","author":"Pace","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.anl.2015.05.005","article-title":"IgG4-related Disease in the Sinonasal Cavity Accompanied by Intranasal Structure Loss","volume":"43","author":"Inoue","year":"2016","journal-title":"Auris Nasus Larynx"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2017.12.011","article-title":"Immunoglobulin G4-related Chronic Rhinosinusitis: A Pitfall in the Differential Diagnosis of Granulomatosis With Polyangiitis, Rosai-Dorfman Disease, and Fungal Rhinosinusitis","volume":"73","author":"Piao","year":"2018","journal-title":"Hum Pathol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2009.09.019","article-title":"A Case of Paranasal Sinus Lesions in IgG4-Related Sclerosing Disease","volume":"142","author":"Ikeda","year":"2010","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.2500\/ar.2016.7.0154","article-title":"Immunoglobulin G4\u2013related Sclerosing Disease of the Paranasal Sinuses: A Case Report and Literature Review","volume":"7","author":"Vandjelovic","year":"2016","journal-title":"Allergy Rhinol (Providence)"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.2500\/ajra.2017.31.4455","article-title":"Immunoglobulin G4 Sinusitis in Association With Aspirin-Exacerbated Respiratory Disease","volume":"31","author":"Johal","year":"2017","journal-title":"Am J Rhinol Allergy"},{"key":"B100","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/00005792-198403000-00001","article-title":"Systemic Vasculitis With Asthma and Eosinophilia: A Clinical Approach to the Churg Strauss Syndrome","volume":"63","author":"Lanham","year":"1984","journal-title":"Med (Baltimore)"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.49.3532","article-title":"Analysis of Serum IgG Subclasses in Churg-Strauss syndrome-The Meaning of Elevated Serum Levels of Igg4","volume":"49","author":"Yamamoto","year":"2010","journal-title":"Intern Med"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.155382","article-title":"IgG4 Immune Response in Churg-Strauss Syndrome","volume":"71","author":"Vaglio","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.51.6074","article-title":"Churg-Strauss Syndrome With a Clinical Condition Similar to IgG4-Related Kidney Disease: A Case Report","volume":"51","author":"Ayuzawa","year":"2012","journal-title":"Intern Med"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.51.7725","article-title":"Churg-Strauss Syndrome Concomitant With Chronic Symmetrical Dacryoadenitis Suggesting Mikulicz\u2019s Disease","volume":"51","author":"Hanioka","year":"2012","journal-title":"Intern Med"},{"key":"B105","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13223-018-0288-z","article-title":"Urticaria and Angioedema","volume":"14","author":"Kanani","year":"2018","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s12016-017-8628-1","article-title":"Uritcaria and Angioedema: An Update on Classification and Pathogenesis","volume":"54","author":"Radonjic-Hoesli","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2017.1282461","article-title":"Current and Future Therapies for the Treatment of Histamine-Induced Angioedema","volume":"18","author":"James","year":"2017","journal-title":"Expert Opin Pharmacother"},{"key":"B108","article-title":"Hypocomplementemia With Cutaneous Vasculitis and Arthritis. Possible Immune Complex Syndrome","volume":"48","author":"McDuffie","year":"1978","journal-title":"Mayo Clin Proc"},{"key":"B109","first-page":"36","article-title":"Mccarty Morgan. Hypocomplementemic Urticarial Vasculitis Syndrome: A Case Report and Literature Review","volume":"5","author":"Buck","year":"2012","journal-title":"J Clin Aesthet Dermatol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.50.4515","article-title":"Hypocomplementemic Urticarial Vasculitis Syndrome Is Associated With High Levels of Serum IgG4: A Clinical Manifestation That Mimics IgG4-related Disease","volume":"50","author":"Wakamatsu","year":"2011","journal-title":"Internal Med"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12868","article-title":"Hypocomplementemic Urticarial Vasculitis Arising in a Patient With Immunoglobulin G4-Related Disease","volume":"55","author":"Takao","year":"2016","journal-title":"Int J Dermatol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1126\/science.1221064","article-title":"New Paradigms in Type 2 Immunity","volume":"337","author":"Pulendran","year":"2012","journal-title":"Science"},{"key":"B113","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/01.mp.0000188308.75043.e4","article-title":"Autoimmune Pancreatitis and Complement Activation System","volume":"32","author":"Muraki","year":"2006","journal-title":"Pancreas"},{"key":"B114","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1007\/s11882-013-0387-3","article-title":"Molecular Basis for Downregulation of C5a-mediated Inflammation by IgG1 Immune Complexes in Allergy and Asthma","volume":"13","author":"Pandey","year":"2013","journal-title":"Curr Allergy Asthma Rep"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310336","article-title":"Pathogenicity of IgG in Patients With IgG4-Related Disease","volume":"65","author":"Shiokawa","year":"2016","journal-title":"Gut"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1172\/JCI84144","article-title":"Current Concepts of Severe Asthma","volume":"126","author":"Ray","year":"2016","journal-title":"J Clin Invest"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.02.004","article-title":"Rhinitis Phenotypes","volume":"8","author":"Mullol","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B118","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/0194599811402296","article-title":"Cryopyrin-Associated Periodic Syndromes: Otolaryngologic and Audiologic Manifestations","volume":"145","author":"Ahmadi","year":"2011","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-219137","author":"Schwartz","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"B120","doi-asserted-by":"publisher","first-page":"244ra90","DOI":"10.1126\/scitranslmed.3008946","article-title":"Intraindividual Genome Expression Analysis Reveals a Specific Molecular Signature of Psoriasis and Eczema","volume":"6","author":"Quaranta","year":"2014","journal-title":"Sci Transl Med"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1097\/meg.0b013e3283297417","article-title":"Allergic Manifestations in Autoimmune Pancreatitis","volume":"21","author":"Kamisawa","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-011-0521-2","article-title":"Proposal for Diagnostic Criteria for IgG4-Related Kidney Disease","volume":"15","author":"Kawano","year":"2011","journal-title":"Clin Exp Nephrol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1111\/all.12320","article-title":"Prevalence of Atopy, Eosinophilia, and IgE Elevation in IgG4-Related Disease","volume":"69","author":"Della Torre","year":"2014","journal-title":"Allergy"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2018.01.014","article-title":"Treatment and Outcomes in Patients With IgG4-Related Disease Using the IgG4 Responder Index","volume":"85","author":"Fern\u00e1ndez-Codina","year":"2018","journal-title":"Joint Bone Spine"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev438","article-title":"Predictors of Disease Relapse in IgG4-Related Disease Following Rituximab","volume":"55","author":"Wallace","year":"2016","journal-title":"Rheumatol (Oxford)"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206605","article-title":"Rituximab for IgG4-Related Disease: A Prospective, Open-Label Trial","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2017.53.9.2693150","article-title":"Dupilumab: Human Monoclonal Antibody Against IL-4Ra for Moderate to Severe Atopic Dermatitis","volume":"53","author":"Paton","year":"2017","journal-title":"Drugs Today (Barc)"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.02.060","article-title":"Dupilumab Treatment Results in Early and Sustained Improvements in Itch in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: Analysis of the Randomized Phase 3 Studies SOLO 1 & SOLO 2, AD ADOL, and CHRONOS","volume":"82","author":"Silverberg","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217076","article-title":"Efficacy of Dupilumab Reveals Therapeutic Target for IgG4-Related Disease: Simultaneous Control of Inflammation and Fibrosis","author":"Yamamoto","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-216945","article-title":"Dupilumab as a Potential Steroid-Sparing Treatment for IgG4-Related Disease","author":"Della-Torre","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2019-0008","article-title":"Dupilumab in the Treatment of Asthma","volume":"11","author":"Grey","year":"2019","journal-title":"Immunotherapy"},{"key":"B132","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1165\/rcmb.2012-0500OC","article-title":"An IL-4\/IL-13 Dual Antagonist Reduces Lung Inflammation, Airway Hyperresponsiveness, and IgE Production in Mice","volume":"49","author":"Kasaian","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1106469","article-title":"Lebrikizumab Treatment in Adults With Asthma","volume":"365","author":"Corren","year":"2011","journal-title":"N Engl J Med"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S211032","article-title":"Therapeutic Potential of Lebrikizumab in the Treatment of Atopic Dermatitis","volume":"13","author":"Loh","year":"2020","journal-title":"J Asthma Allergy"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1902442","DOI":"10.1183\/13993003.02442-2019","article-title":"Phase 2 Trial to Assess Lebrikizumab in Patients With Idiopathich Pulmonary Fibrosis","volume":"57","author":"Maher","year":"2021","journal-title":"Eur Respir J"},{"key":"B136","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12931-019-1138-3","article-title":"Monoclonal Antibodies in Type 2 Asthma: A Systematic Review and Network Meta-Analysis","volume":"20","author":"Edris","year":"2019","journal-title":"Respir Res"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.6.809","article-title":"Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor Beta (1)","volume":"194","author":"Lee","year":"2001","journal-title":"J Exp Med"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.05.029","article-title":"Treatment of Atopic Dermatitis With Tralokinumab, an anti-IL-13 Mab","volume":"143","author":"Wollenberg","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2013-0342OC","article-title":"Targeting interleukin-13 With Tralokinumab Attenuates Lung Fibrosis and Epithelial Damage in a Humanized SCID Idiopathic Pulmonary Fibrosis Model","volume":"50","author":"Murray","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1164\/rccm.201704-0784OC","article-title":"A Phase 2 Randomized Controlled Study of Tralokinumab in Subjects with Idiopathic Pulmonary Fibrosis","volume":"197","author":"Parker","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2020.01.004","article-title":"Roles of Omalizumab in Various Allergic Diseases","volume":"69","author":"Okayama","year":"2020","journal-title":"Allergol Int"},{"key":"B142","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s12016-015-8490-y","article-title":"Off Label Uses of Omalizumab","volume":"50","author":"El-Qutob","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/cea.12668","article-title":"Comparable Actions of Omalizumab on Mast Cells and Basophils","volume":"46","author":"Serrano-Candelas","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.05.036","article-title":"Eosinophilic Esophagitis in Adults Is Associated With IgG4 and Not Mediated by Ige","volume":"147","author":"Clayton","year":"2014","journal-title":"Gastroenterology"},{"key":"B145","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.coph.2014.07.014","article-title":"Eosinophils as a Pharmacological Target for the Treatment of Allergic Diseases","volume":"17","author":"Landolina","year":"2014","journal-title":"Curr Opin Pharmacol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2019.105819","article-title":"Eosinophils, the IL-5\/IL-5R\u03b1 Axis, and the Biologic Effects of Benralizumab in Severe Asthma","volume":"160","author":"Matucci","year":"2019","journal-title":"Respir Med"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.18176\/jiaci.0648","article-title":"Efficacy of Benralizumab and Clinical Course of IgG4 on Eosinophilic Granulomatosis With Polyangiitis","author":"Miyata","year":"2020","journal-title":"J Investig Allergol Clin Immunol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab Treatment in Patients With Severe Eosinophilic Asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N Engl J Med"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.4168\/aair.2020.12.5.885","article-title":"Low-Dose Mepolizumab Effectiveness in Patients Suffering From Eosinophilic Granulomatosis With Polyangiitis","volume":"12","author":"Vultaggio","year":"2020","journal-title":"Allergy Asthma Immunol Res"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1111\/all.14221","article-title":"Efficacy and Safety of Treatment With Biologicals (Benralizumab, Dupilumab, Mepolizumab, Omalizumab and Reslizumab) for Severe Eosinophilic Asthma. A Systematic Review for the EAACI Guidelines-Recommendations on the Use of Biological in Severe Asthma","volume":"75","author":"Agache","year":"2020","journal-title":"Allergy"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01273-4","article-title":"Tslp Inhibitors for Asthma: Current Status and Future Prospects","volume":"80","author":"Matera","year":"2020","journal-title":"Drugs"},{"key":"B152","doi-asserted-by":"publisher","first-page":"AB336","DOI":"10.1016\/j.jaci.2019.12.063","article-title":"Effects of Combined Treatment With Cat Allergen Immunotherapy and Tezepelumab on Nasal Allergen Challenge","volume":"145","author":"Corren","year":"2020","journal-title":"J Allergy Clin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.693192\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T03:14:40Z","timestamp":1672715680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.693192\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,7]]},"references-count":152,"alternative-id":["10.3389\/fimmu.2021.693192"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.693192","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,7]]},"article-number":"693192"}}